The Australian Advantage

The Australian Advantage

Australia provides one of the most compelling environments globally for clinical trials, combining high quality, rapid timelines, and cost-effectiveness with a world-class clinical and medical sector.

Quality

 

Our tailored assay development, qualification, and validation are performed according to international regulatory FDA, EMA, ICH M10 guidelines, industry standards and project specific requirements.

Speed

 

For the most expeditious path into First in Human, Australia offers one of the fastest and most streamlined regulatory approval processes in the world with no IND requirement. Upon completion of nonclinical studies, biopharma can achieve clinical trial approval within 4-5 weeks.

Cost

 

Established since July 2011, The Australian Government’s generous Research and Development (R&D) Tax Incentive allows eligible biotechs can access up to 43.5% cash refund on R&D activities undertaken in Australia.

TAX SPECIALIST CONTACTS

Tax Specialist Contacts:

Feel free to contact one of the many experienced Australian Tax Specialists to assist you through this process;

RDI Partners

+61 8 7223 0122
rdi@rdipartners.com.au

Prime

Tel: (02) 9369 1623
admin@primetaxexperts.com.au

Acclime

+61 3 8689 9997
infoaustralia@acclime.com